Common use of Authorization of Notes Clause in Contracts

Authorization of Notes. The Company may authorize the issue and sale from time to time on or before May 10, 2013, in one or more Series (as hereinafter defined), of up to $100,000,000 aggregate principal amount of its senior promissory notes (the “Notes,” such term to include any such notes issued in substitution therefor pursuant to Section 13). The Notes of any Series shall be substantially in the form set out in Exhibit 1 to Exhibit S, with such changes therefrom, if any, as may be approved by the Purchasers of the Notes of such Series and the Company. Certain capitalized terms used in this Agreement are defined in Schedule B; references to a “Schedule” or an “Exhibit” are, unless otherwise specified, to a Schedule or an Exhibit attached to this Agreement.

Authorization of Notes. The Company may will authorize the issue and sale from time to time on or before May 10, 2013, in one or more Series (as hereinafter defined), of up to $100,000,000 aggregate principal amount of its senior promissory notes 6.28% Senior Guaranteed Notes due April 7, 2020 (the “Notes,” ”, such term to include any such notes issued in substitution therefor pursuant to Section 13). The Notes of any Series shall be substantially in the form set out in Exhibit 1 to Exhibit S, with such changes therefrom, if any, 1. Due and punctual payment of the Guaranteed Obligations (as may defined herein) will be approved unconditionally guaranteed by the Purchasers of Guarantors (the Notes of such Series and the Company“ Subsidiary Guaranty”) as set forth in this Agreement. Certain capitalized and other terms used in this Agreement are defined in Schedule B; and references to a “Schedule” or an “Exhibit” are, unless otherwise specified, to a Schedule or an Exhibit attached to this Agreement.

Authorization of Notes. The Company may will authorize the issue and sale from time to time on or before May 10, 2013, in one or more Series (as hereinafter defined), of up to $100,000,000 20,000,000 aggregate principal amount of its senior promissory notes 5.99% Senior Notes, Series 2024, due August 21, 2034 (each as amended, restated or otherwise modified from time to time pursuant to Section 17, the “Notes,” ”, such term to include any such notes issued in substitution therefor pursuant to Section 13). The Notes of any Series shall be substantially in the form set out in Exhibit 1 to Exhibit S1, with such changes therefrom, if any, as may be approved by the Purchasers of the Notes of such Series each Purchaser and the Company. Certain capitalized and other terms used in this Agreement are defined in Schedule B; and references to a “Schedule” or an “Exhibit” are, unless otherwise specified, to a Schedule or an Exhibit attached to this Agreement.

Authorization of Notes. The Company may will authorize the issue and sale from time to time on or before May 10, 2013, in one or more Series (as hereinafter defined), of up to $100,000,000 aggregate principal amount of its senior promissory notes 5.00% Senior Guaranteed Notes, due February 3, 2042 (the “Notes,” ”) such term to include any such notes issued in substitution therefor pursuant to Section 13). The Notes of any Series shall be substantially in the form forms set out in Exhibit 1 to Exhibit S, with such changes therefrom, if any, 1. Due and punctual payment of the Guaranteed Obligations (as may defined herein) will be approved unconditionally guaranteed by the Purchasers of Guarantors (the Notes of such Series and the Company“ Subsidiary Guaranty”) as set forth in this Agreement. Certain capitalized and other terms used in this Agreement are defined in Schedule B; and references to a “Schedule” or an “Exhibit” are, unless otherwise specified, to a Schedule or an Exhibit attached to this Agreement.

Authorization of Notes. The Company may will authorize the issue and sale from time to time on or before May 10, 2013, in one or more Series (as hereinafter defined), of up to $100,000,000 50,000,000 aggregate principal amount of its senior promissory notes 4.42% Senior Notes, Series 2014, due October 15, 2044 (each as amended, restated or otherwise modified from time to time pursuant to Section 17, the “Notes,” ”, such term to include any such notes issued in substitution therefor pursuant to Section 13). The Notes of any Series shall be substantially in the form set out in Exhibit 1 to Exhibit S1, with such changes therefrom, if any, as may be approved by the Purchasers of the Notes of such Series each Purchaser and the Company. Certain capitalized and other terms used in this Agreement are defined in Schedule B; and references to a “Schedule” or an “Exhibit” are, unless otherwise specified, to a Schedule or an Exhibit attached to this Agreement.

Authorization of Notes. The Company may will authorize the issue and sale from time to time on or before May 10, 2013, in one or more Series (as hereinafter defined), of up to $100,000,000 15,000,000 aggregate principal amount of its senior promissory notes 3.72% Senior Notes, Series 2017A, due November 1, 2027 (as amended, restated or otherwise modified from time to time pursuant to Section 17, the “Notes,” ”), such term to include any such notes issued in substitution therefor pursuant to Section 13). The Notes of any Series shall be substantially in the form set out in Exhibit 1 to Exhibit S1, with such changes therefrom, if any, as may be approved by the Purchasers of the Notes of such Series each Purchaser and the Company. Certain capitalized and other terms used in this Agreement are defined in Schedule B; and references to a “Schedule” or an “Exhibit” are, unless otherwise specified, to a Schedule or an Exhibit attached to this Agreement.

Authorization of Notes. The Company may (as defined in Schedule B) will authorize the issue and sale from time to time on or before May 10, 2013, in one or more Series (as hereinafter defined), of up to $100,000,000 180,000,000 aggregate principal amount of its senior promissory notes 8.31% Senior Notes due August 20, 2014 (the “"Notes,” ", such term to include any such notes issued delivered in substitution therefor or exchange therefor, or in subsequent substitutions or exchanges, pursuant to Section 1313 of this Agreement). The Notes of any Series shall be substantially in the form set out in Exhibit 1 to Exhibit S1, with such changes therefrom, if any, as prescribed in Section 13.4 or as may be approved by the Purchasers of the Notes of such Series each Purchaser and the Company. Certain capitalized terms used in this Agreement are defined in Schedule B; references to a “"Schedule” " or an “"Exhibit” " are, unless otherwise specified, to a Schedule or an Exhibit attached to this Agreement.

Authorization of Notes. The Company may will authorize the issue and sale from time to time on or before May 10, 2013, in one or more Series (as hereinafter defined), of up to $100,000,000 75,000,000 aggregate principal amount of its senior promissory notes Senior Notes, Series 2005-B, due October 30, 2020 (the “Notes,”). As used herein, the term “Notes” such term shall mean all notes originally delivered pursuant to include this Agreement and any such notes issued in substitution therefor pursuant to Section 13)13 of this Agreement. The Notes of any Series shall be substantially in the form set out in Exhibit 1 to Exhibit S, with such changes therefrom, if any, as may be approved by the Purchasers of the Notes of such Series and the Company. Certain capitalized and other terms used in this Agreement are defined in Schedule B; and references to a “Schedule” or an “Exhibit” are, unless otherwise specified, to a Schedule or an Exhibit attached to this Agreement.

Authorization of Notes. The Company may will authorize the issue and sale from time to time on or before May 10, 2013, in one or more Series (as hereinafter defined), of up to $100,000,000 30,000,000 aggregate principal amount of its senior promissory notes 3.43% Senior Notes, Series 2019, due December 18, 2029 (each as amended, restated or otherwise modified from time to time pursuant to Section 17, the “Notes,” ”, such term to include any such notes issued in substitution therefor pursuant to Section 13). The Notes of any Series shall be substantially in the form set out in Exhibit 1 to Exhibit S1, with such changes therefrom, if any, as may be approved by the Purchasers of the Notes of such Series each Purchaser and the Company. Certain capitalized and other terms used in this Agreement are defined in Schedule B; and references to a “Schedule” or an “Exhibit” are, unless otherwise specified, to a Schedule or an Exhibit attached to this Agreement.

Authorization of Notes. The Company may (as defined in Schedule B) will authorize the issue and sale from time to time on or before May 10, 2013, in one or more Series (as hereinafter defined), of up to $100,000,000 180,000,000 aggregate principal amount of its senior promissory notes 8.31% Senior Notes due August 1, 2014 (the “"Notes,” ", such term to include any such notes issued delivered in substitution therefor or exchange therefor, or in subsequent substitutions or exchanges, pursuant to Section 1313 of this Agreement). The Notes of any Series shall be substantially in the form set out in Exhibit 1 to Exhibit S1, with such changes therefrom, if any, as prescribed in Section 13.4 or as may be approved by the Purchasers of the Notes of such Series each Purchaser and the Company. Certain capitalized terms used in this Agreement are defined in Schedule B; references to a “"Schedule” " or an “"Exhibit” " are, unless otherwise specified, to a Schedule or an Exhibit attached to this Agreement.

Authorization of Notes. The Company may will authorize the issue and sale from time to time on or before May 10, 2013, in one or more Series (as hereinafter defined), of up to $100,000,000 30,000,000 aggregate principal amount of its senior promissory notes 3.70% Senior Notes, Series 2016, due August 1, 2026 (each as amended, restated or otherwise modified from time to time pursuant to Section 17, the “Notes,” ”, such term to include any such notes issued in substitution therefor pursuant to Section 13). The Notes of any Series shall be substantially in the form set out in Exhibit 1 to Exhibit S1, with such changes therefrom, if any, as may be approved by the Purchasers of the Notes of such Series each Purchaser and the Company. Certain capitalized and other terms used in this Agreement are defined in Schedule B; and references to a “Schedule” or an “Exhibit” are, unless otherwise specified, to a Schedule or an Exhibit attached to this Agreement.

Authorization of Notes. The Company may will authorize the issue and sale from time to time on or before May 10, 2013, in one or more Series (as hereinafter defined), of up to Cdn. $100,000,000 55,000,000 aggregate original principal amount of its senior promissory notes Senior Subordinated Partial PIK Notes due April 17, 2009 (the “Notes,” "NOTES", such term to include any such notes issued in substitution therefor pursuant to Section 13SECTION 13 of this Agreement (as hereinafter defined) and Additional Notes issued in payment of interest thereon). The Notes of any Series shall be substantially in the form set out in Exhibit 1 to Exhibit SEXHIBIT 1, with such changes therefrom, if any, as may be approved by the Purchasers of the Notes of such Series you and the Company. Certain capitalized terms used in this Agreement are defined in Schedule SCHEDULE B; references to a “"Schedule” " or an “"Exhibit” " are, unless otherwise specified, to a Schedule or an Exhibit attached to this Agreement.

Authorization of Notes. The Company may will authorize the issue and sale from time to time on or before May 10, 2013, in one or more Series (as hereinafter defined), of up to $100,000,000 aggregate principal amount of its senior promissory notes Floating Rate Senior Secured Notes due October 12, 2012 (the “Notes,”). As used herein, the term “Notes” such term shall mean all notes originally delivered pursuant to include this Agreement and any such notes issued in substitution therefor pursuant to Section 13)13 of this Agreement. The Notes of any Series shall be substantially in the form set out in Exhibit 1 to Exhibit S, with such changes therefrom, if any, as may be approved by the Purchasers of the Notes of such Series and the Company. Certain capitalized terms used in this Agreement are defined in Schedule B; and references to a “Schedule” or an “Exhibit” are, unless otherwise specified, to a Schedule or an Exhibit attached to this Agreement.

Authorization of Notes. The Company may will authorize the issue and sale of its $40,000,000 aggregate principal amount 4.04% Senior Notes, Series 2019, due September 12, 2049 (as amended, restated or otherwise modified from time to time on or before May 10pursuant to Section 17, 2013, in one or more Series (are referred to as hereinafter defined), of up to $100,000,000 aggregate principal amount of its senior promissory notes (the “Notes,” ”, such term to include any such notes issued in substitution therefor pursuant to Section 13). The Notes of any Series shall be substantially in the form set out in Exhibit 1 to Exhibit S1, with such changes therefrom, if any, as may be approved by the Purchasers of the Notes of such Series each Purchaser and the Company. Certain capitalized and other terms used in this Agreement are defined in Schedule B; and references to a “Schedule” or an “Exhibit” are, unless otherwise specified, to a Schedule or an Exhibit attached to this Agreement.

Authorization of Notes. The Company may Issuer will authorize the issue and sale from time to time on or before May 10, 2013, of $41,050,763 in one or more Series (as hereinafter defined), of up to $100,000,000 aggregate principal amount of its senior promissory notes 6.07% Senior ESOP Guaranteed Notes due December 31, 2009 (the “"Notes,” ", such term to include any such notes issued in substitution therefor pursuant to Section 1313 of this Agreement or the Other Agreements (as hereinafter defined)). The Notes of any Series shall be substantially in the form set out in Exhibit 1 to Exhibit S1, with such changes therefrom, if any, as may be approved by you, the Purchasers of the Notes of such Series Issuer and the Company. Certain capitalized terms used in this Agreement are defined in Schedule B; references to a “"Schedule” " or an “"Exhibit” " are, unless otherwise specified, to a Schedule or an Exhibit attached to this Agreement.

Authorization of Notes. The Company may will authorize the issue and sale from time to time on or before May 10, 2013, in one or more Series (as hereinafter defined), of up to $100,000,000 125,000,000 aggregate principal amount of its senior promissory notes 2.38% Senior Guaranteed Notes, Series C, due August 17, 2030 (the “Notes,” such term to include any such notes as amended, restated or otherwise modified from time to time pursuant to Section 17 and including any such notes issued in substitution therefor pursuant to Section 13). The Notes of any Series shall be substantially in the form set out in Exhibit 1 to Exhibit SSchedule 1, with such changes therefrom, if any, as may be approved by the Purchasers of the Notes of such Series and the Company. Certain capitalized and other terms used in this Agreement are defined in Schedule B; references A. References to a “Schedule” or an “Exhibit” are, are references to a Schedule attached to this Agreement unless otherwise specified, . References to a Schedule or an Exhibit attached “Section” are references to a Section of this AgreementAgreement unless otherwise specified.

Authorization of Notes. The Company may will authorize the issue and sale of its $40,000,000 aggregate principal amount 3.78% Senior Notes, Series 2020, due September 15, 2040 (as amended, restated or otherwise modified from time to time on or before May 10pursuant to Section 17, 2013, in one or more Series (are referred to as hereinafter defined), of up to $100,000,000 aggregate principal amount of its senior promissory notes (the “Notes,” ”, such term to include any such notes issued in substitution therefor pursuant to Section 13). The Notes of any Series shall be substantially in the form set out in Exhibit 1 to Exhibit S1, with such changes therefrom, if any, as may be approved by the Purchasers of the Notes of such Series each Purchaser and the Company. Certain capitalized and other terms used in this Agreement are defined in Schedule B; and references to a “Schedule” or an “Exhibit” are, unless otherwise specified, to a Schedule or an Exhibit attached to this Agreement.